Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis
- 30 November 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 110 (22), 3493-3500
- https://doi.org/10.1161/01.cir.0000148135.08582.97
Abstract
Background— Vascular lipid accumulation and inflammation are hallmarks of atherosclerosis and perpetuate atherosclerotic plaque development. Mediators of inflammation, ie, interleukin (IL)-6, are elevated in patients with acute coronary syndromes and may contribute to the exacerbation of atherosclerosis. Methods and Results— To assess the role of IL-6 in atherosclerosis, ApoE −/− – IL-6 −/− double-knockout mice were generated, fed a normal chow diet, and housed for 53±4 weeks. Mortality and blood pressure were unaltered. However, serum cholesterol levels and subsequent atherosclerotic lesion formation (oil red O stain) were significantly increased in ApoE −/− – IL-6 −/− mice compared with ApoE −/− , wild-type (WT), and IL-6 −/− mice. Plaques of ApoE −/− – IL-6 −/− mice showed significantly reduced transcript and protein levels of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, collagen I and V, and lysyl oxidase (by reverse transcriptase-polymerase chain reaction and immunohistochemistry). Recruitment of macrophages and leukocytes (Mac3- and CD45-positive staining) into the atherosclerotic lesion was significantly reduced in ApoE −/− – IL-6 −/− mice. The transcript and serum protein (ELISA) levels of IL-10 were significantly reduced. Conclusions— Thus, a lifetime IL-6 deficiency enhances atherosclerotic plaque formation in ApoE K −/− – IL-6 −/− mice and leads to maladaptive vascular developmental processes. These observations are consistent with the notion that baseline levels of IL-6 are required to modulate lipid homeostasis, vascular remodeling, and plaque inflammation in atherosclerosis.This publication has 26 references indexed in Scilit:
- Mechanical Stretch Enhances mRNA Expression and Proenzyme Release of Matrix Metalloproteinase-2 (MMP-2) via NAD(P)H Oxidase–Derived Reactive Oxygen SpeciesCirculation Research, 2003
- Prominent expression oflysyl oxidase during mouse embryonic cardiovascular developmentThe Anatomical Record, 2003
- Low Density Lipoproteins Downregulate Lysyl Oxidase in Vascular Endothelial Cells and the Arterial WallArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Metabolic effects of interleukin‐6 in human splanchnic and adipose tissueJournal Of Physiology-London, 2002
- Transforming Growth Factor-β Mediates Balance Between Inflammation and Fibrosis During Plaque ProgressionArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Attenuation of atherogenesis by systemic and local adenovirus‐mediated gene transfer of interleukin‐10 in LDLr ‐/‐ MiceThe FASEB Journal, 2001
- Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient miceAtherosclerosis, 2001
- The Interleukin-10 Signal Transduction Pathway and Regulation of Gene Expression in Mononuclear PhagocytesJournal of Interferon & Cytokine Research, 1999
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.JCI Insight, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994